As for C4orf54, it has only been found to be downregulated in recurrent inflammatory breast cancer (Qin et al., 2024) and may be associated with obstructive portal vein disease (Besmond et al., 2018). Here, C4orf54 is linked to inflammatory breast carcinoma.